‘Encouraging’ responses seen with durvalumab plus R-CHOP in DLBCLJune 17, 2019B Cell LymphomaAggressive Lymphomas
Antibody targeting ‘do not eat me’ signals is active in AML, MDSJune 11, 2019AMLMyelodysplastic Syndrome
Preprints come to medicine: medRxiv launches with safeguardsJune 11, 2019Business of MedicineTranslational Research
